Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 151.50K | 169.00K | 245.10K | 645.80K | 1.11M |
| Total Receivables | 63.60K | 65.50K | 145.00K | 179.40K | 187.70K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 17.50K | 38.00K | 58.10K | 77.50K | 20.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 232.60K | 272.50K | 448.20K | 902.60K | 1.31M |
|
|
|||||
| Total Current Assets | 232.60K | 272.50K | 448.20K | 902.60K | 1.31M |
| Net Property, Plant & Equipment | 28.50K | 37.70K | 45.90K | 53.60K | 62.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.83M | 2.92M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 568.30K | 560.80K | 560.20K |
| Total Assets | 3.09M | 3.23M | 2.19M | 2.66M | 3.11M |
|
|
|||||
| Total Accounts Payable | 305.70K | 241.80K | 325.60K | 268.20K | 353.90K |
| Total Accrued Expenses | 481.70K | 481.20K | 264.60K | 333.20K | 9.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 787.40K | 723.00K | 590.20K | 601.40K | 363.70K |
|
|
|||||
| Total Current Liabilities | 787.40K | 723.00K | 590.20K | 601.40K | 363.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.21M | 2.28M | -- | -- | -- |
| Total Liabilities | 2.99M | 3.00M | 590.20K | 601.40K | 363.70K |
|
|
|||||
| Common Stock & APIC | 48.26M | 49.66M | 48.94M | 48.44M | 49.05M |
| Retained Earnings | -58.99M | -60.69M | -58.47M | -57.39M | -57.43M |
| Treasury Stock & Other | 10.83M | 11.26M | 11.14M | 11.02M | 11.12M |
| Total Common Equity | 98.00K | 232.00K | 1.61M | 2.06M | 2.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 98.00K | 232.00K | 1.61M | 2.06M | 2.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.50K | -2.60K | -2.60K | -2.60K | -2.60K |
| Total Equity | 95.50K | 229.40K | 1.60M | 2.06M | 2.74M |
|
|
|||||